DR SUSAN LOVE RESEARCH FOUNDATION

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1983

Legal Domicile

Principal Officer

MERIBETH BRAND

Phone

3108280060

Tax Period

2023-07-01 to 2024-06-30

DR SUSAN LOVE RESEARCH FOUNDATION, founded in 1983, is a small nonprofit that reported $998K in total revenue in fiscal year 2023. Revenue fell 34% from the prior year — a significant decline worth monitoring. Expenses of $2.0M exceeded revenue, resulting in a 99% operating deficit.

Mission

THE MISSION OF THE DR. SUSAN LOVE RESEARCH FOUNDATION IS TO ACHIEVE A FUTURE WITHOUT BREAST CANCER BY ENGAGING THE PUBLIC AND SCIENTIFIC COMMUNITIES IN INNOVATIVE RESEARCH.

Program Service Accomplishments

Program 1

Expenses: $870,767 Revenue: $49,975

RESEARCHDR. SUSAN LOVE RESEARCH FOUNDATION CONDUCTS AND COLLABORATES ON STATE OF THE ART RESEARCH WITHIN THE SCIENTIFIC COMMUNITY, SETTING THE STAGE FOR FUTURE MEDICAL BREAKTHROUGHS AND THE...

RESEARCHDR. SUSAN LOVE RESEARCH FOUNDATION CONDUCTS AND COLLABORATES ON STATE OF THE ART RESEARCH WITHIN THE SCIENTIFIC COMMUNITY, SETTING THE STAGE FOR FUTURE MEDICAL BREAKTHROUGHS AND THE ERADICATION OF THE DISEASE. CURRENT COLLABORATIVE PROJECTS INCLUDE THE BIOME OF THE BREAST, MAPPING THE ANATOMY OF THE BREAST DUCTS, MAPPING DCIS, AND LOW COST AUTOMATED ULTRASOUND FOR BREAST CANCER DETECTION AND DIAGNOSIS.

Program 2

Expenses: $766,991

EDUCATION AND OUTREACH PROGRAMDR. SUSAN LOVE RESEARCH FOUNDATION TRANSLATES COMPLEX CONCEPTS REGARDING THE SCIENCE OF BREAST CANCER INTO EASY TO UNDERSTAND INFORMATION IN ORDER TO INFORM, ENGAGE AND EMPOWER PATIENTS, CAREGIVERS AND THE PUBLIC AT LARGE. THROUGH ONLINE AND INTERACTIVE EDUCATIONAL RESOURCES AND MATERIALS, THE FOUNDATION HEIGHTENS UNDERSTANDING OF THE LATEST ADVANCES IN BREAST CANCER CAUSE, DETECTION, PREVENTION AND TREATMENT AND FOSTERS PARTICIPATION IN URGENTLY NEEDED RESEARCH AND ADVOCACY. DR. SUSAN LOVE RESEARCH FOUNDATION DOES THIS THROUGH LOVE RESEARCH ARMY (TO DATE MORE THAN 380,000 WOMEN AND MEN HAVE REGISTERED), IMPATIENT SCIENCE PROGRAM AND INSPIRING NOVEL RESEARCH BY ORGANIZING BIENNIAL SYMPOSIUMS ON THE INTRADUCTAL APPROACH TO BREAST CANCER AND AWARDING PILOT GRANTS TOTALING MORE THAN $1,000,000.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $864,551

Program Service Revenue $49,975

Investment Income $34,226

Other Revenue $49,465

TOTAL REVENUE $998,217

Expense Breakdown

Grants Paid $310,000

Salaries & Benefits $801,137

Fundraising Expenses $247,653

Program Expenses $1,637,758

Other Expenses $876,468

TOTAL EXPENSES $1,987,605

Year-over-Year Comparison

	2023	2022	Change
Revenue	$998,217	$1,502,903	-0.3%
Expenses	$1,987,605	$2,684,693	-0.3%
Net Income	$-989,388	$-1,181,790	-0.2%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$688,971

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
NICOLE WRUBEL	DIRECTOR	5.00	Director	$0	$0	$0
JAKI KACKERT	VICE CHAIRWOMAN	5.00	Director	$0	$0	$0
DR STEPHEN TAPLIN	DIRECTOR	5.00	Director	$0	$0	$0
MERIBETH BRAND	CHAIRWOMAN	5.00	Officer	$0	$0	$0
BRENT HAWKINS	SECRETARY	5.00	Officer	$0	$0	$0
KATE MCLEAN	TREASURER	5.00	Officer	$0	$0	$0
CHRISTOPHER C CONWAY	CEO	40.00	Key Emp	$251,656	$15,817	$267,473
ALEXANDREA CORMIER	MARKETING	40.00	Key Emp	$206,855	$10,708	$217,563
MICHELLE WOODHILL	DEVELOPMENT	40.00	Key Emp	$196,112	$7,823	$203,935

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$998,217	$1,987,605	$407,467	$-989,388
2023	$1,502,903	$2,684,693	$1,738,957	$-1,181,790
2022	$2,470,271	$2,635,333	$2,613,772	$-165,062
2021	$2,542,954	$2,464,496	$3,291,180	$78,458
2020	$3,009,460	$2,471,979	$2,915,436	$537,481
2019	$1,852,727	$2,512,665	$2,267,338	$-659,938
2018	$2,314,296	$2,413,117	$2,877,782	$-98,821